A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease-Modifying Therapies

  • Roberts, Lynden (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Ref Number: HREC/18/CALHN/689 (ERM Project ID: 53075)
NMA SSA Reference Number: SSA/53075/MonH-2019-172725(v1)
Monash Health Ref: RES-19-0000-321X
Effective start/end date12/06/1911/06/24


  • clinical trial
  • treatment efficacy
  • rheumatoid arthritis